Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs
Open Access
- 26 October 2010
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 11 (11) , 4175-4193
Abstract
Early diagnosis of cancer is of pivotal importance to reduce disease-related mortality. There is great need for non-invasive screening methods, yet current screening protocols have limited sensitivity and specificity. The use of serum biomarkers to discriminate cancer patients from healthy persons might be a tool to improve screening programs. Mass spectrometry based proteomics is widely applied as a technology for mapping and identifying peptides and proteins in body fluids. One commonly used approach in proteomics is peptide and protein profiling. Here, we present an overview of profiling methods that have the potential for implementation in a clinical setting and in national screening programs.Keywords
This publication has 77 references indexed in Scilit:
- Detection and identification of potential biomarkers of breast cancerJournal of Cancer Research and Clinical Oncology, 2010
- A Gene-centric Human Proteome ProjectMolecular & Cellular Proteomics, 2010
- Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancerBMC Cancer, 2009
- Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control studyBMC Medical Genomics, 2009
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Analysis and validation of proteomic data generated by tandem mass spectrometryNature Methods, 2007
- Increased Serum Levels of Complement C3a Anaphylatoxin Indicate the Presence of Colorectal TumorsGastroenterology, 2006
- Identification of serum biomarkers for colon cancer by proteomic analysisBritish Journal of Cancer, 2006
- The case for early detectionNature Reviews Cancer, 2003
- Mass spectrometry-based proteomicsNature, 2003